---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-043354"
form_type: "8-K/A"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T07:57:55.913972+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma raises ~$619k via unregistered share sales to non-U.S. persons

## Summary
- On April 30, 2025 sold 724,372 shares for ~$436k to 15 non-U.S. persons under Regulation S.
- Additional subscriptions from May 9-13, 2025: 306,041 shares for ~$183,625 from 7 non-U.S. persons.
- Each investor transferred voting rights to chairman Eugene Jiang via Voting Rights Proxy Agreement.
- Shares are unregistered, restricted for one year, and sold without general solicitation.
- Total gross proceeds from both tranches approximate $619,625.

## SEC filing metadata
- accession: 0001213900-25-043354
- form_type: 8-K/A
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390025043354/0001213900-25-043354-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025043354/ea0241575-8ka_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-043354
- JSON: https://secwatch.observer/filing/0001213900-25-043354.json
- Plain text: https://secwatch.observer/filing/0001213900-25-043354.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.